Gabriel Tajeu

Associate Professor
Health Services Administration and Policy
1301 Cecil B. Moore Ave


Dr. Gabriel S. Tajeu received his doctorate in public health with a concentration in outcomes and econometrics research from the Department of Health Care Organization and Policy at the University of Alabama at Birmingham (UAB). Dr. Tajeu then completed a postdoctoral fellowship in hypertension and cardiovascular disease (CVD) epidemiology in the Department of Medicine and Department of Epidemiology at UAB.

His research focuses on hypertension and CVD outcomes, disparities, costs, and quality of care at the population and health systems level. He is also interested in the cost-effectiveness of antihypertensive medication and statins and has conducted research on antihypertensive medication adherence. Dr. Tajeu utilizes secondary datasets (including Medicare, American Hospital Association Survey, and Hospital Compare, as well as cohort data from the REasons for Geographic and Racial Differences in Stroke study, the Multi-Ethnic Study of Atherosclerosis, and the Jackson Heart Study) in his research. He has also engaged in the collection of primary data on implicit and explicit racial bias among healthcare workers and participated in the development of an intervention to decrease perceived discrimination and improve patient satisfaction in primary care clinics in Alabama.


  • PhD, Public Health, University of Alabama at Birmingham
  • MPH, University of Alabama at Birmingham
  • BA, Political Science, Swarthmore College

Curriculum Vitae 

Courses Taught




HPM 8013

Research Methods in Health Policy


Selected Publications

  • Sarwer, D.B., Wadden, T.A., Ashare, R., Spitzer, J.C., McCuen-Wurst, C., LaGrotte, C., Williams, N., Soans, R., Tewksbury, C., Wu, J., Tajeu, G., & Allison, K.C. (2024). Psychopathology, disordered eating, and impulsivity as predictors of weight loss 24 months after metabolic and bariatric surgery. Surg Obes Relat Dis, 20(7), pp. 634-642. United States. doi: 10.1016/j.soard.2024.01.019

  • Tajeu, G.S., Ruiz-Negrón, N., Moran, A.E., Zhang, Z., Kolm, P., Weintraub, W.S., Bress, A.P., & Bellows, B.K. (2024). Cost of Cardiovascular Disease Event and Cardiovascular Disease Treatment-Related Complication Hospitalizations in the United States. Circ Cardiovasc Qual Outcomes, 17(3), p. e009999. United States. doi: 10.1161/CIRCOUTCOMES.123.009999

  • Tajeu, G.S., Davlyatov, G., Becker, D., Weech-Maldonado, R., & Kazley, A.S. (2024). Association of hospital and market characteristics with 30-day readmission rates from 2009 to 2015. SAGE Open Med, 12, p. 20503121231220815. England. doi: 10.1177/20503121231220815

  • Derington, C.G., Bress, A.P., Berchie, R.O., Herrick, J.S., Shen, J., Ying, J., Greene, T., Tajeu, G.S., Sakhuja, S., Ruiz-Negrón, N., Zhang, Y., Howard, G., Levitan, E.B., Muntner, P., Safford, M.M., Whelton, P.K., Weintraub, W.S., Moran, A.E., & Bellows, B.K. (2023). Estimated Population Health Benefits of Intensive Systolic Blood Pressure Treatment Among SPRINT-Eligible US Adults. Am J Hypertens, 36(9), pp. 498-508. United States. doi: 10.1093/ajh/hpad047

  • Williams, J.H., Tajeu, G.S., Stepanikova, I., Juarez, L.D., Agne, A.A., Stone, J., & Cherrington, A.L. (2023). Perceived discrimination in primary care: Does Payer mix matter? Journal of the National Medical Association, 115(1), pp. 81-89. Elsevier BV. doi: 10.1016/j.jnma.2022.11.001

  • Phillips, A.Z., Kiefe, C.I., Lewis, C.E., Schreiner, P.J., Tajeu, G.S., & Carnethon, M.R. (2022). Alcohol Use and Blood Pressure Among Adults with Hypertension: the Mediating Roles of Health Behaviors. J Gen Intern Med, 37(13), pp. 3388-3395. United States. doi: 10.1007/s11606-021-07375-3

  • Tajeu, G.S., Juarez, L., Williams, J.H., Halanych, J., Stepanikova, I., Agne, A.A., Stone, J., & Cherrington, A.L. (2022). Development of a Multicomponent Intervention to Decrease Racial Bias Among Healthcare Staff. J Gen Intern Med, 37(8), pp. 1970-1979. United States. doi: 10.1007/s11606-022-07464-x

  • Tajeu, G.S., Johnson, E., Buccilla, M., Gadegbeku, C.A., Janick, S., Rubin, D., Soans, R., Eddy, V.J., & Sarwer, D.B. (2022). Changes in Antihypertensive Medication Following Bariatric Surgery. Obes Surg, 32(4), pp. 1312-1324. United States. doi: 10.1007/s11695-022-05893-5

  • Tajeu, G.S., Tsipas, S., Rakotz, M., & Wozniak, G. (2022). Cost-Effectiveness of Recommendations From the Surgeon General's Call-to-Action to Control Hypertension. Am J Hypertens, 35(3), pp. 225-231. United States. doi: 10.1093/ajh/hpab162

  • Weintraub, W.S., Bhatt, D.L., Zhang, Z., Dolman, S., Boden, W.E., Bress, A.P., King, J.B., Bellows, B.K., Tajeu, G.S., Derington, C.G., Johnson, J., Andrade, K., Steg, P.G., Miller, M., Brinton, E.A., Jacobson, T.A., Tardif, J., Ballantyne, C.M., & Kolm, P. (2022). Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment. JAMA Netw Open, 5(2), p. e2148172. United States. doi: 10.1001/jamanetworkopen.2021.48172

  • Tajeu, G.S., Colvin, C.L., Hardy, S.T., Bress, A.P., Gaye, B., Jaeger, B.C., Ogedegbe, G., Sakhuja, S., Sims, M., Shimbo, D., O'Brien, E.C., Spruill, T.M., & Muntner, P. (2022). Prevalence, risk factors, and cardiovascular disease outcomes associated with persistent blood pressure control: The Jackson Heart Study. PLoS One, 17(8), p. e0270675. United States. doi: 10.1371/journal.pone.0270675

  • Cavagna, P., Takombe, J.L., Damorou, J.M., Kouam, C.K., Diop, I.B., Ikama, S.M., Kramoh, K.E., Toure, I.A., Balde, D., Dzudie, A., Ferreira, B., Houenassi, M., Kane, A., Kimbally-Kaki, S.G., Kingue, S., Limbole, E., Kuate, L.M., Mipinda, J.B., N'Guetta, R., Nhavoto, C., Ali, A.S., Gaye, B., Tajeu, G.S., Terline, D.M.D.e., Perier, M.C., Azizi, M., Jouven, X., & Antignac, M. (2021). Blood pressure-lowering medicines implemented in 12 African countries: the cross-sectional multination EIGHT study. BMJ Open, 11(12), p. e049632. England. doi: 10.1136/bmjopen-2021-049632

  • Cavagna, P., Ikama, M.S., Kramoh, K.E., Takombe, J.L., Diop, I.B., Toure, I.A., Balde, D.M., Dzudie, A., Ferreira, B., Houenassi, M.D., Hounkponou, M., Kane, A., Kimbally-Kaki, S.G., Kingue, S., Kouam, C.K., Limbole, E., Kuate, L.M., Mipinda, J.B., N'guetta, R., Nhavoto, C., Damorou, J.M., Ali, A.S., Gaye, B., Tajeu, G.S., Terline, D.M.d.e., Perier, M.C., Azizi, M., Jouven, X., & Antignac, M. (2021). Antihypertensive strategies and hypertension control in Sub-Saharan Africa. Eur J Prev Cardiol, 28(11), pp. e21-e25. England. doi: 10.1177/2047487320937492

  • Kazi, D.S., Wei, P.C., Penko, J., Bellows, B.K., Coxson, P., Bryant, K.B., Fontil, V., Blyler, C.A., Lyles, C., Lynch, K., Ebinger, J., Zhang, Y., Tajeu, G.S., Boylan, R., Pletcher, M.J., Rader, F., Moran, A.E., & Bibbins-Domingo, K. (2021). Scaling Up Pharmacist-Led Blood Pressure Control Programs in Black Barbershops: Projected Population Health Impact and Value. Circulation, 143(24), pp. 2406-2408. United States. doi: 10.1161/CIRCULATIONAHA.120.051782

  • Bryant, K.B., Moran, A.E., Kazi, D.S., Zhang, Y., Penko, J., Ruiz-Negrón, N., Coxson, P., Blyler, C.A., Lynch, K., Cohen, L.P., Tajeu, G.S., Fontil, V., Moy, N.B., Ebinger, J.E., Rader, F., Bibbins-Domingo, K., & Bellows, B.K. (2021). Cost-Effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops. Circulation, 143(24), pp. 2384-2394. United States. doi: 10.1161/CIRCULATIONAHA.120.051683

  • Tajeu, G.S., Colvin, C., Hardy, S.T., Gaye, B., Bress, A.P., Jaeger, B., Ogedegbe, G., Sakhuja, S., Sims, M., OBrien, E.C., Spruill, T.M., Shimbo, D., & Muntner, P. (2021). Abstract 064: Prevalence, Risk Factors And Cardiovascular Outcomes Associated With Persistent Blood Pressure Control: The Jackson Heart Study. Circulation, 143(Suppl_1). doi: 10.1161/circ.143.suppl_1.064

  • Hardy, S.T., Sakhuja, S., Jaeger, B.C., Oparil, S., Akinyelure, O.P., Spruill, T.M., Kalinowski, J., Butler, M., Anstey, D.E., Elfassy, T., Tajeu, G.S., Allen, N.B., Reges, O., Sims, M., Shimbo, D., & Muntner, P. (2021). Maintaining Normal Blood Pressure Across the Life Course: The JHS. Hypertension, 77(5), pp. 1490-1499. United States. doi: 10.1161/HYPERTENSIONAHA.120.16278

  • Sarwer, D.B., Wadden, T.A., Ashare, R.L., Spitzer, J.C., McCuen-Wurst, C., LaGrotte, C., Williams, N.N., Edwards, M., Tewksbury, C., Wu, J., Tajeu, G., & Allison, K.C. (2021). Psychopathology, disordered eating, and impulsivity in patients seeking bariatric surgery. Surg Obes Relat Dis, 17(3), pp. 516-524. United States. doi: 10.1016/j.soard.2020.11.005

  • Langford, A.T., Akinyelure, O.P., Moore, T.L., Howard, G., Min, Y., Hillegass, W.B., Bress, A.P., Tajeu, G.S., Butler, M., Jaeger, B.C., Yano, Y., Shimbo, D., Ogedegbe, G., Calhoun, D., Booth, J.N., & Muntner, P. (2020). Underutilization of Treatment for Black Adults With Apparent Treatment-Resistant Hypertension: JHS and the REGARDS Study. Hypertension, 76(5), pp. 1600-1607. United States. doi: 10.1161/HYPERTENSIONAHA.120.14836

  • Gaye, B., Tajeu, G.S., Vasan, R.S., Lassale, C., Allen, N.B., Singh-Manoux, A., & Jouven, X. (2020). Association of Changes in Cardiovascular Health Metrics and Risk of Subsequent Cardiovascular Disease and Mortality. J Am Heart Assoc, 9(19), p. e017458. England. doi: 10.1161/JAHA.120.017458

  • Tajeu, G.S. & Muntner, P. (2020). Cost-Related Antihypertensive Medication Nonadherence: Action in the Time of COVID-19 and Beyond. Am J Hypertens, 33(9), pp. 816-818. United States. doi: 10.1093/ajh/hpaa085

  • Tajeu, G.S., Safford, M.M., Howard, G., Howard, V.J., Chen, L., Long, D.L., Tanner, R.M., & Muntner, P. (2020). Black-White Differences in Cardiovascular Disease Mortality: A Prospective US Study, 2003-2017. Am J Public Health, 110(5), pp. 696-703. United States. doi: 10.2105/AJPH.2019.305543

  • Gaye, B., Tajeu, G.S., Offredo, L., Vignac, M., Johnson, S., Thomas, F., & Jouven, X. (2020). Temporal trends of cardiovascular health factors among 366 270 French adults. Eur Heart J Qual Care Clin Outcomes, 6(2), pp. 138-146. England. doi: 10.1093/ehjqcco/qcz038

  • Tajeu, G.S., Wu, J., Tewksbury, C., Spitzer, J.C., Gadegbeku, C.A., & Sarwer, D. (2020). Association Of Psychiatric History With Hypertension Among Adults Who Presented For Bariatric Surgery. CIRCULATION, 141. doi: 10.1161/circ.141.suppl_1.P486

  • Tajeu, G.S., Kent, S.T., Huang, L., Bress, A.P., Cuffee, Y., Halpern, M.T., Kronish, I.M., Krousel-Wood, M., Mefford, M.T., Shimbo, D., & Muntner, P. (2019). Antihypertensive Medication Nonpersistence and Low Adherence for Adults <65 Years Initiating Treatment in 2007-2014. Hypertension, 74(1), pp. 35-46. United States. doi: 10.1161/HYPERTENSIONAHA.118.12495

  • Gasoyan, H., Tajeu, G., Halpern, M.T., & Sarwer, D.B. (2019). Reasons for underutilization of bariatric surgery: The role of insurance benefit design. Surg Obes Relat Dis, 15(1), pp. 146-151. United States. doi: 10.1016/j.soard.2018.10.005